If you’ve tried other fibroid treatment methods that were unsuccessful, Uterine Fibroid Embolization can be a plausible option after other treatments have presented unsuccessful.
Even after a myomectomy, Uterine Fibroid Embolization can still be a plausible option for fibroid treatment. Many women who have tried myomectomy and witnessed re-growth in their fibroids look to UFE to treat their existing fibroids. Because the UFE procedure uses tiny particles to successfully block off the blood supply that feed fibroids, the subsequent chance of re-growth for these fibroids are unlikely. Therefore, UFE patients are less likely to witness fibroid re-growth than their myomectomy counterparts.
In addition to a decreased chance of re-growth, UFE patients also experience the advantage of immediate symptom relief. Heavy bleeding, bloating, pain, pressure-all of these symptoms can immediately become lessened after the procedure. On average, many post-operative UFE patients state that their symptoms were either eradicated or lessened following UFE. Therefore, embolization would be an optimal choice of fibroid treatment for your situation. Not to mention a quick recovery period of less then 7 days!
Article courtesy of Fibroids.com
courtesy of ufecenter.com
Getting serious about blocking pain.
Currently there is very little to offer the chronic headache patient. Nearly two thirds of patients discontinue prescription medications due to inadequate relief and side-effects.
Today, establishing an SPG block has never been easier. The patented SphenoCath® offers the practitioner the ability to offer a first-line treatment to the chronic headache patient. The SphenoCath® delivers medication that can sustain pain relief in a 15 minute procedure that is comfortable and quick. With the SphenoCath® an SPG block may be achieved without needles, cotton swabs, atomizer sprays, or systemic narcotics.
can be temporarily blocked, providing relief from various types of pain. The patented SphenoCath® is designed to quickly and comfortably deliver medication to the area of the sphenopalatine ganglion. Read more…
WASHINGTON, March 31 (UPI) — Uterine fibroid embolization — radiology treatment for non-cancerous fibroids of the uterus — improves women’s urinary tract symptoms, U.S. researchers say.
Dr. James B. Spies of Georgetown University Medical Center in Washington says uterine fibroids are benign tumors in the uterus that can cause prolonged, heavy menstrual bleeding severe enough to cause anemia, disabling pelvic pain, urinary frequency, pain during sexual intercourse, miscarriage and interference with fertility.
Twenty percent to 40 percent of women age 35 and older have uterine fibroids of a significant size, but 50 percent of African-American women have fibroids of a significant size.
“Uterine fibroid embolization
continues to be an outstanding treatment choice for women with uterine fibroids, and — based on this study — this non-surgical treatment improves related urinary tract problems,” Spies says in a statement.
“Fibroids can cause a variety of unpleasant, life-disrupting
urinary symptoms for women, such as bladder frequency, urgency and the need to urinate during the night — and uterine fibroid embolization can significantly improve these symptoms and daily life for women.”
The findings were presented at the Society of Interventional Radiology’s 36th annual scientific meeting in Chicago.
Article Courtesy of upi.com